Next Article in Journal
Comparison of Immunogenicity and Safety between a Single Dose and One Booster Trivalent Inactivated Influenza Vaccination in Patients with Chronic Kidney Disease: A 20-Week, Open-Label Trial
Next Article in Special Issue
Factors Affecting Attitudes towards COVID-19 Vaccination: An Online Survey in Slovenia
Previous Article in Journal
Development of Pandemic Vaccines: ERVEBO Case Study
 
 
Article

Article Versions Notes

Vaccines 2021, 9(3), 191; https://doi.org/10.3390/vaccines9030191
Action Date Notes Link
article pdf uploaded. 25 February 2021 13:52 CET Version of Record https://www.mdpi.com/2076-393X/9/3/191/pdf-vor
article xml file uploaded 17 March 2021 05:38 CET Original file -
article xml uploaded. 17 March 2021 05:38 CET Update https://www.mdpi.com/2076-393X/9/3/191/xml
article pdf uploaded. 17 March 2021 05:38 CET Updated version of record https://www.mdpi.com/2076-393X/9/3/191/pdf
article html file updated 17 March 2021 05:40 CET Original file -
article html file updated 25 July 2022 05:00 CEST Update https://www.mdpi.com/2076-393X/9/3/191/html
Back to TopTop